Demeclocycline as a contrast agent for detecting brain neoplasms using confocal microscopy

Physics in Medicine and Biology
Dennis WirthAnna N Yaroslavsky

Abstract

Complete resection of brain tumors improves life expectancy and quality. Thus, there is a strong need for high-resolution detection and microscopically controlled removal of brain neoplasms. The goal of this study was to test demeclocycline as a contrast enhancer for the intraoperative detection of brain tumors. We have imaged benign and cancerous brain tumors using multimodal confocal microscopy. The tumors investigated included pituitary adenoma, meningiomas, glioblastomas, and metastatic brain cancers. Freshly excised brain tissues were stained in 0.75 mg ml(-1) aqueous solution of demeclocyline. Reflectance images were acquired at 402 nm. Fluorescence signals were excited at 402 nm and registered between 500 and 540 nm. After imaging, histological sections were processed from the imaged specimens and compared to the optical images. Fluorescence images highlighted normal and cancerous brain cells, while reflectance images emphasized the morphology of connective tissue. The optical and histological images were in accordance with each other for all types of tumors investigated. Demeclocyline shows promise as a contrast agent for intraoperative detection of brain tumors.

References

Apr 1, 1987·Clinical Endocrinology·J D Nabarro
Dec 23, 1998·Endocrine Reviews·S L Asa, S Ezzat
Sep 19, 2001·Journal of Neurology, Neurosurgery, and Psychiatry·V BiousseN M Oyesiku
Feb 5, 2003·Hormone Research·Mohamad Maghnie
Jul 26, 2003·The Journal of Investigative Dermatology·Anna N YaroslavskyR Rox Anderson
Dec 28, 2005·The American Journal of Medicine·Lynnette K Nieman, Ioannis Ilias
Oct 27, 2007·Neurosurgical Focus·Deborah L ComminsMargaret E Burnett
Dec 15, 2007·Cancer Treatment and Research·Joohee Sul, Jerome B Posner
May 23, 2008·Neurosurgery·Nader Sanai, Mitchel S Berger
Aug 9, 2008·Histochemistry and Cell Biology·Robert Y OsamuraAkira Teramoto
Sep 24, 2010·Cancer Research·Daniel MonleónConcepción López-Ginés
Apr 3, 2012·Journal of Biomedical Optics·Dennis WirthAnna N Yaroslavsky
Oct 24, 2012·International Journal of Medical Sciences·Bo ChenDawei Chen
May 30, 2013·Surgical Neurology International·Melike Pekmezci, Arie Perry

❮ Previous
Next ❯

Citations

Jan 4, 2017·Annals of Surgery·Kiranya E TipirneniEben Rosenthal
Aug 28, 2019·Biomedical Optics Express·Xin FengAnna N Yaroslavsky
Jun 3, 2021·Journal of Clinical Medicine·Francesco RestelliFrancesco Acerbi

❮ Previous
Next ❯

Related Concepts

Related Feeds

CREs: Gene & Cell Therapy

Gene and cell therapy advances have shown promising outcomes for several diseases. The role of cis-regulatory elements (CREs) is crucial in the design of gene therapy vectors. Here is the latest research on CREs in gene and cell therapy.